HSCA Joins Leading Healthcare Organizations in Supporting the CREATES Act (S.974)
We, the undersigned, commend you for your leadership and commitment to reducing out-of-control prescription drug prices and stopping anti-competitive abuses that keep drug prices high. We are encouraged that the Senate Judiciary Committee has noticed a markup of the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974). We thank you for your efforts to move this important piece of legislation through the Committee.
Related Posts
Comments of the Healthcare Supply Chain Association on the Department of Health and Human Services Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Announces Healthcare Cybersecurity Key Considerations
The Healthcare Supply Chain Association (HSCA) today announced the release of key...
Comments of the Healthcare Supply Chain Association (HSCA) on Supported Lifetimes and Legacy Medical Devices
Advances in information technology and medical devices, and increasing...
HSCA Comments on FDA Bulk Substance Guidance
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...